Tatsuhiro Tsujimoto
Overview
Explore the profile of Tatsuhiro Tsujimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
797
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsujimoto T, Hirai T, Kitaoka H, Hata M, Nishio K, Okuchi K, et al.
J Med Ultrason (2001)
. 2016 Jun;
38(3):161-5.
PMID: 27278504
A 73-year-old man underwent coronary artery bypass grafting, abdominal aortic aneurysm resection, and prosthetic implantation as a single procedure in 2002. His progress was favorable until April 2008, when he...
2.
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, et al.
Mediators Inflamm
. 2014 Jan;
2013:495156.
PMID: 24385684
Alcohol is the most common cause of liver disease in the world. Chronic alcohol consumption leads to hepatocellular injury and liver inflammation. Inflammatory cytokines, such as TNF-α and IFN-γ, induce...
3.
Kawaratani H, Tsujimoto T, Kubo T, Aihara Y, Takaya T, Uejima M, et al.
Case Rep Gastroenterol
. 2013 Jul;
7(2):245-50.
PMID: 23874262
A 70-year-old man was referred to our hospital for high-grade fever with chills. He has visited our hospital for alcoholic liver cirrhosis and diabetes mellitus for over 20 years. Nine...
4.
Kawaratani H, Tsujimoto T, Yoshikawa M, Kawanami F, Shirai Y, Yoshiji H, et al.
J Med Case Rep
. 2013 Mar;
7:81.
PMID: 23509998
Introduction: Large cell neuroendocrine carcinoma in the salivary glands is rare. We report a second case of large cell neuroendocrine carcinoma of the submandibular gland diagnosed at autopsy, and a...
5.
Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Aihara Y, et al.
Oncol Lett
. 2012 Aug;
2(1):69-73.
PMID: 22870131
The identification of biomarkers of anti-angiogenic therapy that predict clinical benefit is of vital importance. We previously reported that a combination treatment with clinically available safe agents, specifically angiotensin-converting enzyme...
6.
Tsujimoto T, Kawaratani H, Kitazawa T, Uemura M, Fukui H
Dig Dis Sci
. 2012 Feb;
57(5):1144-51.
PMID: 22367065
Background: Over-proliferation and bacterial translocation of Gram-negative bacilli within the intestinal flora, and increased portal venous levels of endotoxins, are involved in nonalcoholic steatohepatitis (NASH). Aim: To evaluate the innate...
7.
Takaya H, Uemura M, Fujimura Y, Matsumoto M, Matsuyama T, Kato S, et al.
Hepatol Res
. 2012 Feb;
42(5):459-72.
PMID: 22292786
Aim: Decreased plasma ADAMTS13 activity (ADAMTS13:AC) results in accumulation of unusually large von Willebrand factor multimers and platelet thrombi formation. Our aim was to evaluate whether ADAMTS13:AC is a prognostic...
8.
Kawaratani H, Tsujimoto T, Nishimura N, Taniguchi T, Shirai Y, Kin K, et al.
Case Rep Gastroenterol
. 2011 Aug;
5(2):404-10.
PMID: 21829396
We report herein the case of a lobulated and pedunculated hyperplastic polyp in the third portion of the duodenum causing anemia and occult blood in stools, which was detected by...
9.
Kitade M, Yoshiji H, Kojima H, Ikenaka Y, Noguchi R, Kaji K, et al.
Mol Med Rep
. 2011 Apr;
1(4):543-8.
PMID: 21479447
Reactive oxygen species (ROS) is known to play an important role in the pathogenesis of non-alcoholic steatohepatitis (NASH); however, as we previously reported, angiogenesis also plays a pivotal role in...
10.
Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, et al.
Am J Physiol Gastrointest Liver Physiol
. 2011 Mar;
300(6):G1094-104.
PMID: 21372165
Angiotensin II type I receptor blocker and iron chelator reportedly exert suppressive effects on nonalcoholic steatohepatitis (NASH) progression, including liver fibrosis and hepatocarcinogenesis. The aim of this study was to...